Search by Drug Name or NDC
NDC 00046-1106-11 Prempro .45; 1.5 mg/1; mg/1 Details
Prempro .45; 1.5 mg/1; mg/1
Prempro is a ORAL TABLET, SUGAR COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. The primary component is ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE.
Product Information
| NDC | 00046-1106 |
|---|---|
| Product ID | 0046-1106_bec19a55-9af8-4a30-8c06-e51b896aea30 |
| Associated GPIs | 24993002040345 |
| GCN Sequence Number | 052179 |
| GCN Sequence Number Description | estrogen,con/m-progest acet TABLET 0.45-1.5MG ORAL |
| HIC3 | G1A |
| HIC3 Description | ESTROGENIC AGENTS |
| GCN | 19739 |
| HICL Sequence Number | 009649 |
| HICL Sequence Number Description | ESTROGENS, CONJUGATED/MEDROXYPROGESTERONE ACETATE |
| Brand/Generic | Brand |
| Proprietary Name | Prempro |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | conjugated estrogens and medroxyprogesterone acetate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, SUGAR COATED |
| Route | ORAL |
| Active Ingredient Strength | .45; 1.5 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE |
| Labeler Name | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. |
| Pharmaceutical Class | Estrogen Receptor Agonists [MoA], Estrogen [EPC], Estrogens, Conjugated (USP) [CS], Progesterone Congeners [CS], Progestin [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020527 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00046-1106-11 (00046110611)
| NDC Package Code | 0046-1106-11 |
|---|---|
| Billing NDC | 00046110611 |
| Package | 1 BLISTER PACK in 1 CARTON (0046-1106-11) / 28 TABLET, SUGAR COATED in 1 BLISTER PACK |
| Marketing Start Date | 2009-09-21 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8.2834 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | PREMPRO 0.45-1.5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis